BA
CBST

BlackRock Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BlackRock Advisors’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,486
Closed -$1.46M – 3745
2014
Q4 		$1.46M Sell
14,486
-946,226
-98% -$73.6M ﹤0.01% 1318
2014
Q3 		$63.7M Buy
960,712
+223,743
+30% +$14.7M 0.06% 294
2014
Q2 		$51.5M Sell
736,969
-11,315
-2% -$770K 0.05% 346
2014
Q1 		$54.7M Buy
748,284
+739
+0.1% +$55.1K 0.05% 327
2013
Q4 		$51.5M Sell
747,545
-11,365
-1% -$736K 0.05% 336
2013
Q3 		$48.2M Buy
758,910
+2,328
+0.3% +$141K 0.05% 335
2013
Q2 		$36.5M Buy
+756,582
New +$37.2M 0.04% 373

BlackRock Advisors's CBST Position: Q1 2015 in Review

BlackRock Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 14,486 shares — an estimated $1.46M sold.

BlackRock Advisors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $63.7M in Q3 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BlackRock Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Advisors sold 14,486 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.46M.
  • BlackRock Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Advisors's CUBIST PHARMACEUTICALS INC position peaked at $63.7M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.